Current Practices of The Indian Scenario for Therapeutic Drug Monitoring:
Limited Implementation: TDM is not widely used across Indian healthcare.
Centers of Excellence: Some tertiary hospitals offer TDM, especially for drugs like anticonvulsants, antibiotics, and immunosuppressants.
Challenges:
Infrastructure: Limited advanced labs, especially in rural areas.
Costs: High assay and equipment costs hinder broader adoption.
Awareness: Limited understanding of TDM benefits among healthcare providers.
Regulatory Barriers: No standardized TDM guidelines across India.
Pharmacogenetic Considerations:
Genetic Diversity: India’s genetic diversity calls for personalized dosing.
Research: Studies focus on understanding pharmacogenetic differences in the population.
Government and Institutional Initiatives:
National Health Programs: Efforts to include TDM in managing diseases like tuberculosis and HIV.
Collaborations: Partnerships with academic and healthcare institutions to enhance TDM.
Future Prospects:
Technology: Point-of-care testing could improve TDM accessibility.
Education: Integrating TDM into medical and pharmacy training.
Policy: Developing national guidelines to standardize TDM.
